Wacker doubles production area at biologics plant

Published: 8-Mar-2010
Manufacturing Research & Development Finance Pharmaceutical

Wacker Chemie officially opens its new biologics plant in Jena, Germany.

Wacker Chemie has officially opened its new production facility for pharmaceutical proteins, or biologics in Jena, Germany.

The firm says the expansion will enable it to meet growing demand for biologically manufactured pharmaceuticals used to treat cancer, multiple sclerosis and hepatitis, among other indications.

The expansion, together with a building for process development and quality control completed last year, brings the total investment at the plant to Euro 18m.

Wacker has almost doubled the production area at the GMP-certified site. A new facility for product purification also allows up to three times higher product yields per batch.

"Demand for advanced biotech products is growing worldwide. Innovative, biotechnological processes such as Wacker's ESETEC secretion system allow us to meet demand and continue to shape the developments in biotechnology here in Germany," said Auguste Williams, a member of Wacker's Executive Board.

"We now have an ideal system for developing the sophisticated processes and analytical techniques of modern, microbe-based biologics," added Thomas Maier, managing director of Wacker Biotech.

"This allows Wacker to optimise the entire process chain, from lab operations to industrial GMP production. Customers thus benefit from a full process and analysis package provided from a single source. And with the expansion of our production capacities, we can now make our innovative ESETEC secretion technology available to more customers."

Traditional production methods aside, the focus of the new unit is on Wacker's ESETEC and DENSETEC proprietary technologies, which enable simpler, more cost-efficient and high-yield production of biologics for the pharmaceuticals industry.



See more

You may also like

Research & Development

Lindus Health and Quotient Sciences team up to accelerate drug development process

Read more
The pair will provide biotech and pharma sponsors with enhanced patient recruitment for early-stage clinical trials and a direct path from first-in-human to proof-of-concept trials

Trending Articles

  1. New Osaka-developed reverse genetics system accelerates norovirus vaccine and drug research Osaka University scientists have created the first simple, efficient system to generate infectious human noroviruses, paving the way for faster antiviral screening and vaccine development
  2. GlaxoSmithKline and Oxford BioTherapeutics partner to advance antibody-based therapeutics for cancer The collaboration leverages OBT's proprietary OGAP-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targets
  3. PLL Therapeutics opens New Zealand subsidiary to accelerate ALS clinical research in Asia-Pacific The new entity will support Phase II ALS patient recruitment in New Zealand (where incidence rates exceed the global average) and expand PLL Therapeutics’ footprint in the Asia-Pacific neurodegenerative disease research landscape
  4. Marchesini Group and AST announce strategic partnership to strengthen aseptic production capacity and expand global market presence Marchesini Group, a leader in pharmaceutical packaging machinery, and AST, a US leader in the drug product manufacturing industry, have entered a strategic partnership that combines the expertise, technologies, and global reach of two highly respected industry leaders
  5. From data to decisions: applying criticality and failure probability in process risk mitigation This article presents an exploration of how structured, data-based methods enhance quality control, optimise specifications and improve process robustness throughout the product lifecycle

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Research & Development

Lindus Health and Quotient Sciences team up to accelerate drug development process

The pair will provide biotech and pharma sponsors with enhanced patient recruitment for early-stage clinical trials and a direct path from first-in-human to proof-of-concept trials
Manufacturing

Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom

The certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Manufacturing

LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener

Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more
Research & Development

CAR T-cell therapy shows promise for restoring gut health and intestinal regeneration

Researchers at Cold Spring Harbor Laboratory have demonstrated that anti-uPAR CAR T-cell therapy can clear senescent cells and restore intestinal regeneration, offering a potential new approach to treating age- and radiation-related gut damage
Manufacturing

IMA Active launches new tablet press range in stunning film location

The Italy-based pharmaceutical equipment company has launched its innovative new DOMINA AND SOLIDA at Villa Erba on Lake Como, which has historic ties to the pharmaceutical industry
Manufacturing

Particology joins £8.2m consortium to drive greener, more efficient medicines manufacturing

The company has been selected for Innovate UK’s £54m Sustainable Medicines Manufacturing Innovation Programme, leading crystallisation research to cut waste, reduce energy use and accelerate next-generation pharmaceutical production
Manufacturing

Valve diagnostics: providing new insights for medical and lab applications

Across a range of medical and laboratory applications, confirmation of liquid flow status is critical, but integrating sensors or electronics to check the performance of functions like valve switching adds design complexity
Subscribe now